An oceanography journal has retracted a 2017 paper by a group of researchers in China after learning from a reader that one of the authors had a bogus affiliation in the United States. The paper, “Southward migrations of the Atlantic Equatorial Currents during the Younger Dryas,” appeared in early spring in Limnology and Oceanography, a … Continue reading Bogus affiliation scuttles paper on Atlantic currents
SAGE recently retracted three 2015 papers from one of its journals after the publisher found the articles were accepted with faked peer reviews. The retraction notices call out the authors responsible for submitting the reviews. This trio of retractions is the second batch of papers withdrawn by Technology in Cancer Research & Treatment over faked … Continue reading SAGE journal retracts three more papers after discovering faked reviews
The father of a boy with a rare genetic mutation has accused a scientist of exploiting his child by proclaiming the defect a “genetic syndrome” and naming it after herself. At an impasse with scientists investigating, publicizing, and interpreting his son’s condition, the father seems willing to use any leverage he can muster to remove … Continue reading Fearing “stigmatization,” patient’s father seeks retraction of paper on rare genetic mutation
Researchers in China thought they had sequenced the genomes of two snails that help transmit diseases to other species — an important first step to stopping the spread. But their hopes were soon dashed after they realized they had misidentified one of the snails. The researchers published their findings earlier this year in the journal … Continue reading Researchers retract a paper when they realize they had sequenced the wrong snail’s genome
A 2016 paper exploring the biology of prostate cancer has been retracted due to figure manipulation. According to the retraction notice, a reader contacted the journal Clinical Cancer Research in late 2016 with concerns that similar bands appeared multiple times in two images. The editors asked the paper’s corresponding author, Shahriar Koochekpour, about the issue … Continue reading “The article must be retracted:” Journal pulls prostate cancer study
Four hundred eighty-six authors have been found guilty of misconduct by the Chinese government, the fall-out from a sweep of retractions by one journal earlier this year. In April, Tumor Biology retracted 107 papers that had been accepted based on faked reviews. Since many of the authors were based in China, the country’s Ministry of Science … Continue reading Nearly 500 researchers guilty of misconduct, says Chinese gov’t investigation
The week at Retraction Watch featured authors making a difficult decision to retract once-promising findings about gliobastoma, and sanctions for a researcher in whose lab image manipulations were found. Here’s what was happening elsewhere:
Image duplications and unsupported data continue to plague a network of cancer researchers that includes the former vice chancellor for research at the University of California, Los Angeles, James Economou. On July 2, the editors at Cancer Research retracted a 2011 paper that Economou published as last author, saying it suffered from image duplication and … Continue reading Drip, drip: UCLA investigation finds more image duplications
WASHINGTON, D.C — Last week, former brain scientist Christian Kreipke stared down the third set of research misconduct allegations against him since 2011. Or, possibly, according to him, it was the third iteration of the same research misconduct allegations he’s faced for years, a piling on by the most powerful of the three institutions out … Continue reading Ex-Wayne State scientist, ORI square off in court
Different journals follow different editorial policies — but we’ve never seen any charge money to authors who want to appeal an editorial decision. Until now. Recently, a criminal justice researcher sent us links to multiple journals that charge appeal fees. For instance, the Journal of Accounting Research says authors must pay $500 for each submission — … Continue reading Want to appeal a journal’s rejection? Sure — that’ll be $700